YK
Yeleswaram Krishnaswamy
OFFICERM
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Yeleswaram Krishnaswamy. Officer active across 1 company, notably Rapport Therapeutics, Inc.. In total, 11 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €3.7m. Activity tracked since 25 March 2026. The latest transaction was filed on 24 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Yeleswaram Krishnaswamy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
13,160 shares@ US$49.99830.028% mcap15.1% of flowCommon StockSEC:0001193125-26-368244:0
20,799 shares@ US$50.31110.045% mcap24.0% of flowCommon StockSEC:0001193125-26-368244:1
16,201 shares@ US$51.05760.036% mcap19.0% of flowCommon StockSEC:0001193125-26-368244:2
404 shares@ US$49.900.0009% mcap1.1% of flowCommon StockSEC:0001193125-26-359189:0
20,225 shares@ US$39.99230.041% mcap100.0% of flowCommon StockSEC:0001193125-26-167091:0
500 shares@ US$34.980.0009% mcap1.2% of flowCommon StockSEC:0001193125-26-154908:0
9,165 shares@ US$34.9740.016% mcap21.3% of flowCommon StockSEC:0001193125-26-154908:1
10,200 shares@ US$35.07810.018% mcap23.7% of flowCommon StockSEC:0001193125-26-154908:2
360 shares@ US$34.900.8% of flowCommon StockSEC:0001193125-26-149725:0
10,115 shares@ US$29.990616.9% of flowCommon StockSEC:0001193125-26-126410:0
9,000 sharesCommon StockSEC:0001193125-26-002469:0
About Yeleswaram Krishnaswamy
Yeleswaram Krishnaswamy is a declarant linked to Rapport Therapeutics, Inc., where the listed role is Chief Development Officer. Across 7 filings in total, the 7 sampled filings, from 2026-01-05 to 2026-04-21, are sales for a total of EUR 1548977.